THE SECRET SOCIETY OF MILLION DOLLAR DREAMS/IRELAND
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
im the same as you differnt prices ive read your post on here for a while and your posts are good...straight up...no bs....will you give me your email as i dont have pm on here i have something interesting going on
OK im going to predict that we get news here tomorrow evening...it nearly ran today and the volume is up so maybe just maybe its coming through and the mm know it....anyone??
SLOW AND STEADY WINS THE RACE....
O I HEAR YOU...we are in a winner here...entb long
MR JACKSON ...thank you for that and it explains a lot...whats do you think on this now this...??
I AGREE about the mm..but hopefully its on the move......watch the last 20 minutes here that should give us an indication of whats happening
HI GUYS I HAVE SENT SEVERAL EMAILS AND NO REPLYS...SO I JUST DONT KNOW....fingers crossed because with good news this could be one hell of a stock....it went to 12 dollars over a year ago...i dont think it will go back up that far but who know maybe a dollar or so
Great Wall Builders (GWBU) Finalizing Contract with Coopsette Soc Coop For Distribution of Start FEED Units ant that was on june the 5ft 2012
...so why would the other company need to test them again if there only distributors...????????? anyone
W T F GWBU
WHAT HAPPENED THERE
WE WILL BREAK THROUGH THIS JUST WATCH
hey wirges dont get me wrong i really do hope your right...and thats why i bought this stock and i have a large holding also...and i wish everyone the best of luck with it may we all make money
GOOD ARTICLE BUT WE NEED PROOF....BOTTON LINE
HEY PARIS DONT SEND ME MESSAGES I DONT WANT TO LISTEN TO YOUR SHIT
THIS STOCK SHOULD RUN PAST 027....
COME ON BABY SHOW ME THE MONEY...GO GWBU
thanks aly im going to mail you now...
hey aly hope all is well and yes fingers crossed....i said i would do some dd over the weekend but didnt because i was ill had to go to hosiptal but all is good now.....and if this works out tomorrow i feel a holiday coming on ....best of luck tomorrow
yes i do think it will be a yes and this is why.....
the first phase....dose over 500 mg.......4 billion market
the second phase....dose 200 to 500 mg....40 billion dollar market
new nda to the fda by the end of feb.....ceo stated that for 200 to 500 mg..huge market.......different doses same drug
1 nce status covers both doses....new drug status....5 years ...
i dont know im just guessing....any comments anyone???
hey guys best of luck tomorrow
hey jr how are you in the last interview the ceo stated that the next 10Q would give details off all this ...orders and revenue....there last annual report was filed on 11/14/2011...just lets hope its filled by or on tuesday
IS THAT ARTICLE FROM OCT 2009 ??Wed Oct 21, 2009 4:05pm EDT
Therinject to Bring Its Cancer Research, Intellectual Property and Former
National Cancer Institute Researcher under the Entest BioMedical Umbrella
SAN DIEGO--(Business Wire)--
Entest BioMedical Inc. (OTCBB: ENTB) announced today that it has signed a letter
of intent to acquire Therinject LLC. Therinject LLC is involved with Cancer
Research, marker testing / development and "bead" formation used in vaccine
development. Company Chairman David Koos noted, "Entest BioMedical has already
established a joint venture with Therinject LLC and Bio-Matrix Scientific Group
Inc. (OTCBB: BMSN). I believe this is an obvious natural fit and removes any
potential conflicts between each company`s goals."
Therinject`s Managing Principal, Steven Josephs, PhD stated, "I have been
involved with new develops taking place at Entest for some time. I`m excited
that Therinject will become an Entest company. I believe we are doing some
extremely important work in cancer treatment, COPD and potentially Multiple
Sclerosis. With the linking of these companies together, we should get further
in our research at a much faster pace."
Once a definitive agreement is in place, Therinject LLC will become a wholly
owned subsidiary of Entest BioMedical Inc. This transaction is subject to
reaching final agreement on terms and conditions.
About Entest BioMedical Inc.:
Entest BioMedical Inc. (OTCBB: ENTB) is a majority owned subsidiary of
Bio-Matrix Scientific Group Inc (OTCBB: BMSN). The Company is involved with the
development of stem cell therapy treatments for Chronic Obstructive Pulmonary
Disease (COPD), immuno-cancer therapies, testing procedures for diabetes, stem
cell research applications for diabetes and other illnesses. The Company also is
involved with medical device development (including stem cell extraction
instrumentation).
Disclaimer
This news release may contain forward-looking statements. Forward-looking
statements are inherently subject to risks and uncertainties, some of which
cannot be predicted or quantified. Future events and actual results could differ
materially from those set forth in, contemplated by, or underlying the
forward-looking statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect of government
regulation, competition and other material risks.
Entest BioMedical Inc.
David R. Koos, Chairman & CEO
619-702-1404 Direct
619-330-2328 Fax
info@EntestBio.com
www.EntestBio.com
Copyright Business Wire 2009
HI NORTON IS THAT ARTICLE FROM OCT 2009 ??Wed Oct 21, 2009 4:05pm EDT
Therinject to Bring Its Cancer Research, Intellectual Property and Former
National Cancer Institute Researcher under the Entest BioMedical Umbrella
SAN DIEGO--(Business Wire)--
Entest BioMedical Inc. (OTCBB: ENTB) announced today that it has signed a letter
of intent to acquire Therinject LLC. Therinject LLC is involved with Cancer
Research, marker testing / development and "bead" formation used in vaccine
development. Company Chairman David Koos noted, "Entest BioMedical has already
established a joint venture with Therinject LLC and Bio-Matrix Scientific Group
Inc. (OTCBB: BMSN). I believe this is an obvious natural fit and removes any
potential conflicts between each company`s goals."
Therinject`s Managing Principal, Steven Josephs, PhD stated, "I have been
involved with new develops taking place at Entest for some time. I`m excited
that Therinject will become an Entest company. I believe we are doing some
extremely important work in cancer treatment, COPD and potentially Multiple
Sclerosis. With the linking of these companies together, we should get further
in our research at a much faster pace."
Once a definitive agreement is in place, Therinject LLC will become a wholly
owned subsidiary of Entest BioMedical Inc. This transaction is subject to
reaching final agreement on terms and conditions.
About Entest BioMedical Inc.:
Entest BioMedical Inc. (OTCBB: ENTB) is a majority owned subsidiary of
Bio-Matrix Scientific Group Inc (OTCBB: BMSN). The Company is involved with the
development of stem cell therapy treatments for Chronic Obstructive Pulmonary
Disease (COPD), immuno-cancer therapies, testing procedures for diabetes, stem
cell research applications for diabetes and other illnesses. The Company also is
involved with medical device development (including stem cell extraction
instrumentation).
Disclaimer
This news release may contain forward-looking statements. Forward-looking
statements are inherently subject to risks and uncertainties, some of which
cannot be predicted or quantified. Future events and actual results could differ
materially from those set forth in, contemplated by, or underlying the
forward-looking statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect of government
regulation, competition and other material risks.
Entest BioMedical Inc.
David R. Koos, Chairman & CEO
619-702-1404 Direct
619-330-2328 Fax
info@EntestBio.com
www.EntestBio.com
Copyright Business Wire 2009
i hear you ...i think if nothing happens tuesday its time to leave the building ....lets keep our fingers crossed and hope for the best ...just think of this....dec2011 and jan 12.....this stock was worth 12 dollars with no revenue.....think think think.....envoy the weekend everyone
i hear you aly im going to try and look into this, some dd over the weekend see what i can find .....anyone else thoughts please??.....personally i think im going to just wait till tuesday and see what happens,but ill do some dd also
CEO NEEDS A KICK IN THE ASS
COME ON GWBU W T F IS GOING ON
O i like the sound of that
BUY A NICE BOAT AND LIVE BY THE LAKE
THAT ARTICLE IS 2 MONTHS OLD
THAT ARTICLE IS 2 MONTHS OLD
CHECK THIS OUT........MEDISTEM SUPPLY ENTB WITH THAT SAME CELL endometrial regenerative cells....NOW READ THIS...MediStem
Ischemia -- the lack of blood flow -- produces heart pain and actual heart attacks. When ischemia takes place in limbs, they may require amputation. To restore blood circulation before it's too late, San Diego-based MediStem is testing a special type of stem cell to make new and sturdy blood vessels.
These cells, called endometrial regenerative cells, are derived from menstrual blood. They don't cause an allergic reaction so they're not rejected, said Alan Lewis, the company's CEO.
"We call them nature's regenerative powerhouse," Lewis said. The cells reproduce prolifically and are very good at creating new blood vessels. The U.S. Food and Drug Administration has approved their use for clinical trials.
CHECK THIS OUT........MEDISTEM SUPPLY ENTB WITH THAT SAME CELL endometrial regenerative cells....NOW READ THIS...MediStem
Ischemia -- the lack of blood flow -- produces heart pain and actual heart attacks. When ischemia takes place in limbs, they may require amputation. To restore blood circulation before it's too late, San Diego-based MediStem is testing a special type of stem cell to make new and sturdy blood vessels.
These cells, called endometrial regenerative cells, are derived from menstrual blood. They don't cause an allergic reaction so they're not rejected, said Alan Lewis, the company's CEO.
"We call them nature's regenerative powerhouse," Lewis said. The cells reproduce prolifically and are very good at creating new blood vessels. The U.S. Food and Drug Administration has approved their use for clinical trials.
Quote:
Drugmakers may win approval from U.S. regulators for “breakthrough” therapies after a single round of studies, rather than three, in an effort to speed them to patients, a Food and Drug Administration official said.
http://www.bloomberg.com/news/2013-02-11/innovative-drugs-may-win-u-s-approval-after-early-trials.html
This would be a great advantage
OK LAST thursday this started to move it went up 30% just at the end of the day and then back down friday because of no news....so keep a close eye on it with maybe 20 minutes to go till the bell....if it starts rising well...we could be in for a fist full of dollars
BOGIN FUNNY THAT....in ireland it means.....im bogin im filthy dirty need to wash big time
I THINK BIG NEWS TUESDAY,,,ANYONE???
I THINK BIG NEWS TUESDAY... ANYONE???
HEY CARL hi you doing...its not looking good so far,but hopefully we will see the 10Q this evening...
i agree with everything your saying and hopefully we will do well from this...i seen somewhere a months ago they price being 1025 dollars being the wholesale price..thats about 750 euro pretty cheap when your using lots of fuel